Your browser doesn't support javascript.
loading
Chemotherapy and CDK4/6 Inhibition in Cancer Treatment: Timing Is Everything.
Fassl, Anne; Sicinski, Piotr.
Afiliação
  • Fassl A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavantik Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Sicinski P; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavantik Institute, Harvard Medical School, Boston, MA 02115, USA. Electronic address: peter_sicinski@dfci.harvard.edu.
Cancer Cell ; 37(3): 265-267, 2020 03 16.
Article em En | MEDLINE | ID: mdl-32183946
Chemotherapy remains the main treatment option for patients with several tumor types. In this issue of Cancer Cell, Salvador-Barbero et al. demonstrate that treatment with CDK4/6 inhibitors after application of taxanes (or other chemotherapeutic compounds) strongly potentiates the anti-tumor effect due to repression of DNA repair machinery.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article